[
    [
        {
            "time": "",
            "original_text": "一年净赚33亿却难有话语权，HPV疫苗或纳入免疫规划，智飞生物难阻毛利率、增速双双下滑 盈利能力下降",
            "features": {
                "keywords": [
                    "HPV疫苗",
                    "免疫规划",
                    "智飞生物",
                    "毛利率",
                    "增速下滑",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "一年净赚33亿却难有话语权，HPV疫苗或纳入免疫规划，智飞生物难阻毛利率、增速双双下滑 盈利能力下降",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "疫苗股普遍造好，达安基因涨7%",
            "features": {
                "keywords": [
                    "疫苗股",
                    "达安基因",
                    "涨幅"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "疫苗股普遍造好，达安基因涨7%",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "医药行业2020年报及2021年一季报业绩前瞻：2020分化巨大 21Q1恢复良好",
            "features": {
                "keywords": [
                    "医药行业",
                    "年报",
                    "一季报",
                    "业绩",
                    "分化",
                    "恢复"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业2020年报及2021年一季报业绩前瞻：2020分化巨大 21Q1恢复良好",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "中泰证券：国内新冠病毒疫苗进入兑现期，关注有望首批兑现利润的相关企业",
            "features": {
                "keywords": [
                    "中泰证券",
                    "新冠疫苗",
                    "兑现期",
                    "利润",
                    "相关企业"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "中泰证券：国内新冠病毒疫苗进入兑现期，关注有望首批兑现利润的相关企业",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]